Evidence map›Paper›PMID 34183109›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2021

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB.

C A Rodriguez, M B Brooks, O Aibana, C D Mitnick, M F Franke

Abstract readLetter
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  3. Observational
  4. Article
  5. Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C A RodriguezDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA.
M B BrooksDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA.
O AibanaDepartment of Internal Medicine, University of Texas Health Science Center - Houston, McGovern Medical School, Houston, TX, USA.
C D MitnickDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA.
M F FrankeDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA.

Funding

Strengthening evidence on optimal multidrug-resistant tuberculosis treatment regimens through improved epidemiologic methodsR01AI146095 · NIAID · HARVARD MEDICAL SCHOOL · PI FRANKE, MOLLY FORREST · 2020 to 2024
$3.6M
Causal inference for the treatment and management of multidrug-resistant tuberculosisF31AI157333 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RODRIGUEZ, CARLY · 2021 to 2021
$30k
NIAID NIH HHS F31 AI157333NIAID NIH HHS R01 AI146095
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsHumansSputumTreatment OutcomeAntitubercular Agents

Identifiers

PMID34183109
PMCPMC8259120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.